LGALS9 and systemic lupus erythematosus: Regarding Gal9, non-significant trends toward elevated levels in patients with increased DA were found in SLE (p = 0.0306), PS (p = 0.0094), and RA (p = 0.0240) (Supplementary Figure S2).